Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.
$93.23 -1.87 (-1.97%)
As of 06/28/2022 15:59:57 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.